Randomized Controlled Trials and Assessment of Drug Safety David W. J. ClarkDavid M. CoulterFrank M. C. Besag Editorial 20 November 2012 Pages: 1057 - 1061
A Computerized Database for Adverse Drug Reactions Jimmy JoseBeena JimmyPadma G. M. Rao Commentary 20 November 2012 Pages: 1063 - 1067
The Afterlife of Drugs and the Role of PharmEcovigilance Christian G. DaughtonIlene Sue Ruhoy Leading Article 20 November 2012 Pages: 1069 - 1082
Long-Term Consequences of Drugs on the Paediatric Cardiovascular System Elizabeth HausnerMonica L. FiszmanSolomon Sobel Review Article 20 November 2012 Pages: 1083 - 1096
Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir Stephen TooveyCraig RaynerDavid Ready Review Article 20 November 2012 Pages: 1097 - 1114
Statin-Associated Psychiatric Adverse Events Marco TuccoriFrancesco LapiMario Del Tacca Original Research Article 20 November 2012 Pages: 1115 - 1123
Role of Cytochrome P450 Polymorphisms in the Development of Pulmonary Drug Toxicity Petal A. H. M. WijnenMarjolein DrentOtto Bekers Original Research Article 20 November 2012 Pages: 1125 - 1134
Serious Events with Infliximab in Patients with Inflammatory Bowel Disease Hilbert S. de VriesMartijn G. H. van OijenDirk J. de Jong Original Research Article 20 November 2012 Pages: 1135 - 1144
Stratification for Spontaneous Report Databases Johan HopstadiusG. Niklas NorénI. Ralph Edwards Correspondence 20 November 2012 Pages: 1145 - 1147